A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial

This phase II trial describes the use of TIP chemotherapy (paclitaxel, ifosfamide and cisplatin) as salvage for patients with metastatic germ cell cancer (GCC) who have failed initial BEP (bleomycin, etoposide and cisplatin) chemotherapy. Patients with first relapse following BEP for metastatic GCC,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mead, G M, Cullen, M H, Huddart, R, Harper, P, Rustin, G J S, Cook, P A, Stenning, S P, Mason, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361542/
https://www.ncbi.nlm.nih.gov/pubmed/15999102
http://dx.doi.org/10.1038/sj.bjc.6602682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361542/
https://www.ncbi.nlm.nih.gov/pubmed/15999102
http://dx.doi.org/10.1038/sj.bjc.6602682

Ejemplares similares